PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33191068-12	2021	In addition, the SPR experiments revealed that the quercetin and isoquercitrin were combined with SARS-CoV-2 Spike protein rather than Angiotensin-converting enzyme 2, while astragaloside IV and rutin were combined with ACE2 rather than SARS-CoV-2 Spike protein.	Quercetin	51-60	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	109-114	
33191068-12	2021	In addition, the SPR experiments revealed that the quercetin and isoquercitrin were combined with SARS-CoV-2 Spike protein rather than Angiotensin-converting enzyme 2, while astragaloside IV and rutin were combined with ACE2 rather than SARS-CoV-2 Spike protein.	Quercetin	51-60	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	248-253	
34920080-10	2022	Quercetin, an HO-1 inducer, reduced syncytia formation and spike protein expression.	Quercetin	0-9	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	59-64	
32593613-2	2020	In silico modelling has identified several natural products including quercetin as potential highly effective disruptors of the initial infection process involving binding to the interface between the SARS-CoV-2 (Covid-19) Viral Spike Protein and the epithelial cell Angiotensin Converting Enzyme-2 (ACE2) protein.	Quercetin	70-79	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	229-234	
32768503-7	2020	Cyanidin may inhibit RNA polymerase function and, Quercetin is found to block interaction sites on the viral spike.	Quercetin	50-59	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	109-114	
34607208-6	2021	Quercetin derivatives (CMP-4, CMP-5, CMP-6 and CMP-7) were found highly stable in the active domain of NRP1, ACE2 and Spike protein.	Quercetin	0-9	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	118-123	
34574194-5	2021	Some of these compounds (e.g., curcumin, gallic acid or quercetin) already showed capacity to limit the infection of viruses by inhibiting entry into the cell through its binding to protein Spike, regulating the expression of angiotensin-converting enzyme 2, disrupting the replication in cells by inhibition of viral proteases, and/or suppressing and modulating the host"s immune response.	Quercetin	56-65	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	190-195	
35262828-0	2022	In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.	Quercetin	31-40	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	83-88	
35262828-2	2022	The current study was therefore conducted to examine the noted novel derivatives of quercetin present in plant sources as an immune modulator and as an antiviral molecule in the COVID-19 disease and also to study their affinity of binding with potential three targets reported for coronavirus, i.e., papain-like protease, spike protein receptor-binding domain, and 3C-like protease.	Quercetin	84-93	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	322-327	
35262828-6	2022	Docking was performed finally using PyRx having AutoDock Vina to identify the efficacy of binding between quercetin derivatives with papain-like protease, spike protein receptor-binding domain, and 3C-like protease.	Quercetin	106-115	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	155-160	
35578172-0	2022	Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein.	Quercetin	85-94	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	141-146	
35578172-10	2022	CONCLUSION: The compounds, Quercetin and Genistein, can inhibit the TMPRSS2 guided priming of the spike protein.	Quercetin	27-36	surface glycoprotein	Severe acute respiratory syndrome coronavirus 2	98-103